Thorac Cardiovasc Surg 1982; 30(2): 109-112
DOI: 10.1055/s-2007-1022224
© Georg Thieme Verlag Stuttgart · New York

Clinical Experience with Activated Clotting Time (ACT) Controlled Heparinization in Open Heart Surgery

O. K. Albrechtsen, S. Stenbjerg, E. Berg
  • Department of Cardiac Surgery and the Coagulation Laboratory, Bloodbank and Tissue-typing Laboratory, University Hospital, Aarhus, Denmark
Further Information

Publication History

1981

Publication Date:
19 March 2008 (online)

Summary

The activated clotting time (ACT) as a control of heparinization has been analysed in 30 consecutive adult patients during extracorporeal circulation (ECC).

Among 26 patients without preoperative anticoagulation preoperative coagulation studies revealed only minor abnormalities. In 4 patients, who were anticoagulated with coumarins preoperatively, the results of the preoperative coagulation studies revealed abnormalities, typical of this medication. The changes in these patients did not affect the ACT.

A dose-response curve was constructed before ECC was established. This curve showed considerable individual Variation. The average heparin dose required to obtain an ACT of 480 seconds was 394 units/kg body weight with a range of 200 to 700 units/kg. From these dose-response curves it could be calculated, that a standard protocol for heparin would imply administration of 800 units/kg, if all patients were to obtain an ACT of 480 seconds or more. If only 300 units/kg were given, only 30% of the patients would receive proper heparinization.

The Protamine dosage after ECC can be evaluated from the dose-response curve. Thus complete neutralization of heparin was obtained in 28 patients with a single dose of protamine whereas 2 patients required a further dose.

A good correlation was established between the ACT and the whole blood clotting time.

The ACT obtained 4 hours after neutralization of heparin showed a mean value similar to that obtained immediately after neutralization.

The postoperative blood loss in this group of patients was considerably reduced when compared to a preceding series, in which heparin was administered and neutralized according to a fixed protocol.

In conclusion ACT controlled heparinization carrres the advantage of an individualized, readily adjusted, and accurately neutralized dose of heparin by the use of a simple technique which does not require the help of expert laboratory personnel.

    >